U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
SIPLIZUMAB
KUW1QG1ZM3
Investigational
General
Record Details
Names
7
Classification
6
Identifiers
9
Relationships
1
Active Moiety
1
Characteristic Attributes
2
SIPLIZUMAB
KUW1QG1ZM3
Investigational
General
Approval Year
Unknown
139,594
Record Details
Substance Class
Protein
Protein Type
MONOCLONAL ANTIBODY
Protein Sub Type
IGG1
Sequence Origin
HUMANIZED RAT
Sequence Type
UNKNOWN
Record UNII
KUW1QG1ZM3
Record Status
Validated (UNII)
Record Version
23
22
21
20
19
18
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
Names
7
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
SIPLIZUMAB
Official Name
English
siplizumab [INN]
Common Name
English
MEDI-507
Code
English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD2 (ANTIGEN)) (HUMAN-RAT MONOCLONAL MEDI-507 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-RAT MONOCLONAL MEDI-507 LIGHT CHAIN, DIMER
Common Name
English
SIPLIZUMAB [USAN]
Common Name
English
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Classification
6
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated/Withdrawn
ORPHAN DRUG
Designated/Withdrawn
Treatment of T-cell lymphomas
FDA ORPHAN DRUG
170603
Designated/Withdrawn
ORPHAN DRUG
Designated/Withdrawn
Treatment of graft-versus-host disease.
FDA ORPHAN DRUG
116498
Withdrawn
EU ORPHAN DRUG
Withdrawn
Treatment of T-cell and NK-cell neoplasms
EU-Orphan Drug
EU/3/06/383
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
NCI_THESAURUS
C20401
Designated
ORPHAN DRUG
Designated
Prevention of solid organ transplant rejection
FDA ORPHAN DRUG
623917
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Identifiers
9
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
FDA UNII
KUW1QG1ZM3
PRIMARY
INN
8251
PRIMARY
EVMPD
SUB33504
PRIMARY
CAS
288392-69-8
PRIMARY
CHEMBL
CHEMBL2108742
PRIMARY
Showing 1 to 5 of 9 entries
Previous
1
2
Next
Relationships
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
ZU51KFJ7F3
CD2
TARGET -> INHIBITOR
Showing 1 to 1 of 1 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
KUW1QG1ZM3
SIPLIZUMAB
ACTIVE MOIETY
Showing 1 to 1 of 1 entries
Previous
1
Next
Characteristic Attributes
2
Show
5
20
100
All
entries
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Molecular Formula
CHEMICAL
ESTIMATED
MOL_WEIGHT:ESTIMATE
CHEMICAL
ESTIMATE 150000 AMU (average)
Showing 1 to 2 of 2 entries
Previous
1
Next
